Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/37670
Title: Long-lasting humoral and cellular immune responses elicited by immunization with recombinant chimeras of the Plasmodium vivax circumsporozoite protein
Authors: Morais Martins Almeida, Ana Paula
Dias, Mariana Oliveira
Fagundes Vieira, Carolina de Almeida
Chavez-Olortegui, Carlos
Gazzineli, Ricardo Tostes
Rodrigues, Mauricio Martins [UNIFESP]
Fujiwara, Ricardo Toshio
Bruna-Romero, Oscar
Universidade Federal de Minas Gerais (UFMG)
Universidade Federal de São Paulo (UNIFESP)
Universidade Federal de Santa Catarina (UFSC)
Keywords: Plasmodium vivax
Malaria
Vaccine
Virus-like particle
Circumsporozoite protein
Issue Date: 17-Apr-2014
Publisher: Elsevier B.V.
Citation: Vaccine. Oxford: Elsevier B.V., v. 32, n. 19, p. 2181-2187, 2014.
Abstract: The circumsporozoite protein (CSP), the most abundant surface antigen of sporozoites, has been extensively studied in different expression platforms as a vaccine candidate. Clinical trials have shown the necessity of broad and highly avid humoral immune responses together with high numbers of CSP-specific TCD4+ and TCD8+ cells, especially those producing IFN gamma, to induce protection. To this aim, we designed two distinct recombinant immunogens based on previously-described antigenic fragments of Plasmodium vivax CSP (PvCSP) to be used as vaccine candidates. the first one is a virus-like particle (VLP) comprising the repeat region of PvCSP (B and TCD4+ epitopes) within the loop of the hepatitis B virus core antigen (HBcAgPvCSP). the second one is a PvCSP multi-epitope polypeptide, rPvCSP-ME, designed based on antigenic regions of PvCSP recognized by lymphocytes of individuals from endemic areas. Mice immunized with 2 doses of these proteins, administered individually or combined and formulated in Montanide ISA 720 adjuvant, were able to induce strong effector and memory humoral responses with IgG titers ranging from 10(4) to 10(5) and avidity indexes toward full-length PvCSP reaching up to 66%, even 3 months after the last immunization. Furthermore, balanced Th1/Th2 responses were generated, as determined by titers of IgG subclasses and further confirmed by ELISPOT analyses, which detected that these vaccination protocols were able to elicit long-term IFN gamma and IL-2-secreting memory T-cells. Overall, these results show that our vaccine candidates generate, in mice, immune responses against regions within PvCSP that have been associated with protection against malaria in humans. (c) 2014 Elsevier B.V. All rights reserved.
URI: http://repositorio.unifesp.br/handle/11600/37670
ISSN: 0264-410X
Other Identifiers: http://dx.doi.org/10.1016/j.vaccine.2014.02.053
Appears in Collections:Em verificação - Geral

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.